Author

A. K. Chopra

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Microbiology· 4

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 3 Research Focus:host-pathogen & immune response· 3 Organism:mouse· 3 Organism:Arabidopsis· 1 Research Focus:drug response / drug discovery· 1 Assay:electronic health records· 1 Approach:genetic perturbation / CRISPR· 1

Frequent Co-Authors

J. Sha· 3 shared P. B. Kilgore· 3 shared A. Drelich· 2 shared E. Hendrix· 2 shared H. Batra· 2 shared J. Zhu· 2 shared N. Ananthaswamy· 2 shared S. Jain· 2 shared

Activity by Year

2020-2022 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 36 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

3 shared papersMicrobiology

J. Sha

Mutual co-authors in cluster

Author profile →

4 papers

Recent·Most cited

MicrobiologybioRxivApr 28, 2022

A bacteriophage-based, highly efficacious, needle and adjuvant-free, mucosal COVID-19 vaccine

J. Zhu, S. Jain, J. Sha…·V. B. Rao

This paper develops a bacteriophage-based mucosal vaccine that induces strong immune responses and protects against SARS-CoV-2 and its variants without requiring needles or adjuvants.

DOI 10.1128/mbio.01822-22

mouseexperimental assay

𝕏 PostBluesky

MicrobiologybioRxivOct 28, 2021

Combinatorial viral vector-based and live-attenuated vaccines without an adjuvant to generate broader immune responses to effectively combat pneumonic plague

P. B. Kilgore, J. Sha, E. Hendrix…·A. K. Chopra

This study evaluates a combination of adenovirus vector and live-attenuated vaccines for pneumonic plague, showing that a two-dose regimen provides full protection against multiple challenges.

DOI 10.1128/mbio.03223-21

mouseexperimental assay

𝕏 PostBluesky

MicrobiologybioRxivJan 19, 2021

A Universal Bacteriophage T4 Nanoparticle Platform to Design Multiplex SARS-CoV-2 Vaccine Candidates by CRISPR Engineering

V. B. Rao, J. Zhu, N. Ananthaswamy…·A. K. Chopra

This paper develops a CRISPR-engineered bacteriophage T4 nanoparticle platform to create multiplex SARS-CoV-2 vaccine candidates, showing potent immune responses and protection in animal models.

DOI 10.1126/sciadv.abh1547

mousegenetic perturbation / CRISPR

𝕏 PostBluesky

MicrobiologybioRxivPreprintJan 16, 2020

Gut-associated bacteria invade the midgut epithelium of Aedes aegypti and stimulate innate immunity and suppress Zika virus infection in cells.

S. Hegde, D. Voronin, A. Casas-Sanchez…·G. L. Hughes

This study shows gut bacteria invade mosquito cells, activate immune pathways, and reduce Zika virus infection.

DOI 10.1101/866897

Arabidopsiselectronic health records

𝕏 PostBluesky